Plasma cell leukemia occuring in a patient with thrombocythemia treated with hyroxyurea and busulphan

Leukemia and Lymphoma

Volumn 45, Issue 4, 2004, Pages 821-824

  Candoni, Anna ^a   Tiribelli, Mario ^a   Fanin, Renato ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Essential thrombocythemia; P glycoprotein; Plasma cell leukemia

Indexed keywords

ALLOPURINOL; BICARBONATE; BUSULFAN; CORTICOSTEROID; DEXAMETHASONE; DOXORUBICIN; GLYCOPROTEIN P; HYDROXYUREA; MULTIDRUG RESISTANCE PROTEIN; PAMIDRONIC ACID; PHOSPHONIC ACID DERIVATIVE; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE; VINCRISTINE;

ADULT; ARTICLE; BONE DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CASE REPORT; CHROMOSOME 7; CHROMOSOME DELETION; CHRONIC DISEASE; COMORBIDITY; CYTOFLUOROMETRY; DISEASE SEVERITY; HUMAN; KARYOTYPING; LYMPHOPROLIFERATIVE DISEASE; MALE; MEDICAL LITERATURE; MYELOPROLIFERATIVE DISORDER; PLASMA CELL; PLASMA CELL LEUKEMIA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SECOND CANCER; SURVIVAL TIME; THROMBOCYTHEMIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CHROMOSOME DELETION; FATAL OUTCOME; HUMANS; HYDROXYUREA; LEUKEMIA, PLASMACYTIC; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; P-GLYCOPROTEIN; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 1342266118     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001615710     Document Type: Article

References (24)

1. Kyle, R.A., Maldonado, J.E. and Bayrd, E.D. (1974) "Plasma cell leukemia. Report on 17 cases", Arch. Intern. Med., 133, 813-818.
2. Kosmo, M.A. and Gale, R.P. (1987) "Plasma cell leukemia", Semin. Hematol., 24, 202-208.
3. Bernasconi, C., Castelli, G., Pagnucco, G. and Brusamolino, E. (1989) "Plasma cell leukemia: a report on 15 patients", Eur. J. Haematol., 51(suppl), 76-83.
4. Garcia Sanz, R., Orafao, A., Gonzales, M., Tabernero, M., Blade', J., Moro, M.J., et al. (1999) "Primary Plasma Cell Leukemia: Clinical, Immunophenotyping, DNA Ploidy, and Cytogenetic Characteristics", Blood 93(3), 1032-1037.
5. Pasqualetti, P., Festuccia, V., Collacciani, A., Acitelli, P. and Casale, R. (1996) "Plasma cell leukemia. A report of 11 patients and review of the literature", Panminerva Med., 38(3), 179-184.
6. Hayman, S.R. and Fonseca, R. (2001) "Plasma cell leukemia", Curr. Treat. Options Oncol., 2(3), 205-216.
7. Prosper, F., Borbolla, J.R., Rifon, J., Cuesta, B., Fernandez, J., Pinacho, A., et al. (1992) "Coexistence of Essential Thrombocythemia and Multiple Myeloma", Ann. Hematol., 65(2), 103-105.
8. Kelsey, P.R. and Patel, K. (1995) "Essential Thrombocythaemia followed by multiple myeloma in the same patient", Clin. Lab. Haematol., 17(4), 349-351.
9. Costello, R., Sainty, D., Bouabdallah, J.P., Fernand, J.P., Delmer, A., Divine, M., et al. (2001) "Primary plasma cell leukaemia: a report of 18 cases", Leuk. Res., 25(2), 103-107.
10. Mak, Y.K., Chan, C.H., Chen, Y.T., Lau, S.M., So, C.C. and Wong, K.F. (2003) "Consolidation therapy with autologus blood stem cell transplantation in a patient with primary plasma cell leukaemia", Clin. Lab. Haem., 25, 55-58.
11. Vela-Ojeda, J., Garcia-Ruiz Esparanza, M.A., Rosas-Cabral, A., et al. (2002) "Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukaemia", Ann. Hematol., 81(7), 362-367.
12. Christou, L., Hatzimichael, E., Chaidos, A., Tsiara, S. and Bourantas, K.L. (2001) "Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone", Eur. J. Haematol., 67, 51-53.
13. Panizo, C., Rifon, J., Rodriguez-Wilhelmi, P., Cuesta, B. and Rocha, E. (1999) "Long-term survival in primary plasma cell leukemia after therapy with VAD, autologus blood stem cell transplantation and interferon-alpha", Acta. Haematol., 101(4), 193-196.
14. Sica, S., Chiusolo, P., Salutari, P., Piccirillo, N., Laurenti, L., Ortu La Barbera, E., et al. (1998) "Long-lasting complete remission in plasma cell leukemia after aggressive chemotherapy and CD34-selected autologus peripheral blood progenitor cell transplant: molecular follow-up of minimal residual disease", Bone Marrow Transplant, 22(8), 823-825.
15. Hovenga, S., Wolf de J, T.M., Klip, H., et al. (1997) "Consolidation therapy with autologus stem cell transplantation in plasma cell leukaemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature", Bone Marrow Transplant, 20, 901-904.
16. Schwarzenbach, H. (2002) "Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma", Med. Oncol., 19(2), 87-104.
17. Raaijmakers, H.G.P., Izquierdo, M.A.I., Lokhorts, H.M., Dee Leeuw, C., et al. (1998) "Lung-Resistance-Related Protein Expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in Multiple Myeloma", Blood, 9, 1029-1036.
18. Fishman, M.N. and Sullivan, D.M. (2001) "Application of Resistance Reversal Agent in Hematologic Malignances", Current Clinical Practice Hematol., 5, 343-358.
19. Mohrbacher, A.F., Gregory, S.A., Gabriel, D.A., Rusk, J.M. and Giles, F.J. (2002) "Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study", Cancer, 15, 2645-2652.
20. Liozon, E., Brigaudeau, C., Trimoreau, F., Desangles, F., Fermeaux, V., Praloran, V., et al. (1997) "Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature", Hematol. Cell. Ther., 39(1), 11-18.
21. Finazzi, G., Ruggieri, M., Rodeghiero, F. and Barbui, T. (2000) "Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea; long-term follow-up of a randomized clinical trial", Br. J. Haematol., 110, 577-583.
22. Murphy, S., Peterson, I., Iland, H. and Laszlo, J. (1997) "Experience of the Polycythemia Vera Study Group with Essential Thrombocythaemia: a final report on diagnostic criteria, survival and leukemic transition by treatment", Seminars in Hematology, 34, 29-39.
23. Randi, M.L., Fabris, F. and Girolami, A. (2000) "Leukemia and myelodysplasia effect of multiple cytotoxic therapy in Essential Thrombocythemia", Leuk. Lymphoma, 37, 379-385.
24. Raspadori, D., Damiani, D., Michieli, M.G., et al. (2002) "CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome", Haematologica, 87, 1135-1140.